ACE2 is indeed upregulated by IFN treatment and in COVID-19 patients.32,33 Therefore, the interactions between SARS-CoV-2 and the host type I and III IFN responses merit extensive investigation. This evidence concerns the gene IFNA1 and COVID-19.